Eli Lilly acquires Orna Therapeutics in deal worth up to 2.4 billion dollars

Eli Lilly announced today that it will acquire Orna Therapeutics for up to $2.4 billion in cash. The deal expands the company's therapy development pipeline.

Insights:
Eli Lilly and Company announced today, February 9, that it will acquire therapy developer Orna Therapeutics for up to $2.4 billion in cash. This major corporate acquisition will result in the transfer of ownership of Orna to Lilly, representing a material transaction with direct financial implications for both the buyer and the target.
The Eli Lilly logo is displayed on one of the company's offices in San Diego, California, U.S., on September 17, 2020. REUTERS/Mike Blake
The Eli Lilly logo is displayed on one of the company's offices in San Diego, California, U.S., on September 17, 2020. REUTERS/Mike Blake